Results 1 to 10 of about 134,137 (295)

Clinical outcomes of myocarditis after SARS-CoV-2 mRNA vaccination in four Nordic countries: population based cohort study

BMJ Medicine, 2023
Objective To investigate the clinical outcomes of myocarditis associated with mRNA vaccines against the SARS-CoV-2 virus compared with other types of myocarditis.Design Population based cohort study.Setting Nationwide register data from four Nordic ...
Øystein Karlstad, Lars Køber, Tommi Härkänen, Anders Husby, Jørgen Vinsløv Hansen, Anders Hviid, Rickard Ljung, Jesper Dahl, Hanne Løvdal Gulseth, Tiina Heliö, Nina Gunnes, Petteri Hovi, Nicklas Pihlström   +12 more
doaj   +2 more sources

Long-term effects on cardiac function and symptoms in patients with myocarditis following COVID-19 vaccination: the ECHOVID-19 Long-term Study [PDF]

Open Heart
Background The long-term effects of myocarditis following COVID-19 vaccination on cardiac function and symptoms remain unclear.Purpose To assess the long-term effects of myocarditis following COVID-19 vaccination on cardiac function, inflammatory ...
Manan Pareek, Tor Biering-Sørensen, Anders Hviid, Filip Soeskov Davidovski, Kristoffer Grundtvig Skaarup, Mohammad Nizar Ramadan, Caroline Espersen, Ali Hikmat Al-Rubai, Ayat Khoraizat, Niklas Dyrby Johansen, Mats Christian Højbjerg Lassen, Tyra Grove   +11 more
doaj   +2 more sources

Comparison of Multisystem Inflammatory Syndrome in Children–Related Myocarditis, Classic Viral Myocarditis, and COVID‐19 Vaccine‐Related Myocarditis in Children

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Although rare, classic viral myocarditis in the pediatric population is a disease that carries significant morbidity and mortality. Since 2020, myocarditis has been a common component of multisystem inflammatory syndrome in children (MIS‐C ...
Trisha Patel, Michael Kelleman, Zachary West, Andrew Peter, Matthew Dove, Arene Butto, Matthew E. Oster   +6 more
doaj   +1 more source

Circulating Spike Protein Detected in Post–COVID-19 mRNA Vaccine Myocarditis

Circulation, 2023
Background: Cases of adolescents and young adults developing myocarditis after vaccination with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–targeted mRNA vaccines have been reported globally, but the underlying immunoprofiles of these ...
L. Yonker, Zoe N Swank, Y. Bartsch, M. D. Burns, A. Kane, B. Boribong, Jameson P. Davis, M. Loiselle, T. Novak, Y. Senussi, Chi-An Cheng, Eleanor Burgess, A. Edlow, J. Chou, A. Dionne, D. Balaguru, Manuella Lahoud-Rahme, M. Arditi, B. Julg, A. Randolph, G. Alter, A. Fasano, David R. Walt   +22 more
semanticscholar   +1 more source

Revitalizing myocarditis treatment through gut microbiota modulation: unveiling a promising therapeutic avenue

Frontiers in Cellular and Infection Microbiology, 2023
Numerous studies have demonstrated that gut microbiota plays an important role in the development and treatment of different cardiovascular diseases, including hypertension, heart failure, myocardial infarction, arrhythmia, and atherosclerosis ...
Jingyue Wang, Jingyue Wang, Xianfeng Zhang, Xinyu Yang, Xinyu Yang, Hang Yu, Mengmeng Bu, Jie Fu, Zhengwei Zhang, Hui Xu, Jiachun Hu, Jinyue Lu, Haojian Zhang, Zhao Zhai, Wei Yang, Xiaodan Wu, Yan Wang, Qian Tong   +17 more
doaj   +1 more source

Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis.

Cancer Discovery, 2023
Immune-checkpoint-inhibitor (ICI)-associated myotoxicity involves the heart (myocarditis) and skeletal muscles (myositis), which frequently occur concurrently and is highly fatal.
J. Salem, M. Bretagne, B. Abbar, S. Leonard-Louis, S. Ederhy, alban redheuil, Samia Boussouar, L. Nguyen, Adrien Procureur, Frederic Stein, C. Fenioux, Perrine Devos, P. Gougis, M. Dres, A. Demoule, D. Psimaras, T. Lenglet, T. Maisonobe, M. Pineton de Chambrun, G. Hékimian, C. Straus, J. Gonzalez-Bermejo, D. Klatzmann, A. Rigolet, P. Guillaume-Jugnot, N. Champtiaux, O. Benveniste, N. Weiss, S. Saheb, P. Rouvier, I. Plu, E. Gandjbakhch, M. Kerneis, N. Hammoudi, N. Zahr, C. Llontop, C. Morélot-Panzini, L. Lehmann, Juan Qin, J. Moslehi, M. Rosenzwajg, T. Similowski, Y. Allenbach   +42 more
semanticscholar   +1 more source

COVID-19, Myocarditis and Pericarditis

Circulation Research, 2023
Viral infections are a leading cause of myocarditis and pericarditis worldwide, conditions that frequently coexist. Myocarditis and pericarditis were some of the early comorbidities associated with SARS-CoV-2 infection and COVID-19.
D. Fairweather, Danielle J Beetler, D. D. Di Florio, Nicolas Musigk, Bettina Heidecker, L. Cooper   +5 more
semanticscholar   +1 more source

Multi-organ Immune-Related Adverse Event Is a Risk Factor of Immune Checkpoint Inhibitor-Associated Myocarditis in Cancer Patients: A Multi-center Study

Frontiers in Immunology, 2022
Background and ObjectiveImmune checkpoint inhibitor (ICI)-associated myocarditis is a fatal immune-related adverse events (irAEs), which is prone to affecting multiple organ systems.
Xiaohong Xie, Liqiang Wang, Liqiang Wang, Yingqing Li, Yan Xu, Jianhui Wu, Xinqing Lin, Wen Lin, Qicong Mai, Zhanhong Chen, Jiexia Zhang, Zhanhong Xie, Yinyin Qin, Ming Liu, Mingjun Lu, Bihui Luo, Chengzhi Zhou   +16 more
doaj   +1 more source

Myocarditis With COVID-19 mRNA Vaccines

Circulation, 2021
Supplemental Digital Content is available in the text. Myocarditis has been recognized as a rare complication of coronavirus disease 2019 (COVID-19) mRNA vaccinations, especially in young adult and adolescent males.
B. Bozkurt, I. Kamat, P. Hotez
semanticscholar   +1 more source

COVID myocarditis: a review of the literature

Monaldi Archives for Chest Disease, 2023
Myocarditis is a potentially fatal complication of coronavirus disease 2019 (COVID‐19), which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) virus. COVID‐19 myocarditis appears to have distinct inflammatory characteristics
Angelica Cersosimo, Mattia Di Pasquale, Gianmarco Arabia, Marco Metra, Enrico Vizzardi   +4 more
doaj   +1 more source